ABP-68.3

N/A

Report date: 2024/01/26 15:36:00

Base Information

Drug NameABP-68.3

Drug Alias NameABP-68.3ABP68.3

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionT-cell surface glycoprotein CD3 epsilon chain inhibitorsCluster of differentiation 47 inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonists

TargetsT-cell surface glycoprotein CD3 epsilon chainCluster of differentiation 47Receptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesYM BioSciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesYM BioSciences Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A